Publication | Open Access
Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial
20
Citations
19
References
2020
Year
Most residual disease after nCRT missed by endoscopic biopsies was located in the mucosa. Active surveillance could be improved by more sampling and considering submucosal biopsies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1